Pascal Soriot, the CEO of AstraZeneca, was paid £17.7 million in 2025. There is a possibility that in 2026 he will earn approximately £20 million.
Radu Burcă
Current Affairs
Foto: profimedia.com
Always see our news on Google
AstraZeneca announced that its CEO, Pascal Soriot, earned £17.7 million in 2025, an increase of over 6% compared to 2024, when he earned £16.6 million. This includes annual bonuses of £4.3 million and long-term shares worth £11.6 million. The company reported a profit increase of 40% and a rise in shares over the last 12 months, and Soriot could benefit from an additional salary increase in 2026, with a possible maximum package of £19.6 million. Although AstraZeneca is expanding its operations in the US and China and investing in weight loss drugs, it has reduced investments in the UK, canceling a £450 million expansion for a vaccine facility last year. Soriot has consistently been named the highest-paid CEO in the UK, earning 176 times the average salary of an AstraZeneca employee.
Sources
Latest News
23:03
Mark Carney and Volodymyr Zelenskyy signed a declaration for a 100-year security and economic partnership
22:49
Robert Negoiță supports Sorin Grindeanu for the position of prime minister and says that he could obtain the most votes in Parliament
22:28
Alina Gorghiu criticizes Ilie Bolojan and does not rule out the interim prime minister’s resignation
22:07
Ukrainian authorities report four dead and 60 injured after the Russian attack on a shopping center in Pavlograd
21:53
Hadja Lahbib praises Romania / European commissioner highlights 49 interventions in support of other states over the past decade
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
